{"url_path":"/sec/imvt/10-k/2026/item-1b","section_key":"item-1b","section_title":"Item 1B Unresolved Staff Comments","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1764013/0001764013-26-000064-index.html","accession_number":"0001764013-26-000064","cik":"0001764013","ticker":"IMVT","issuer_name":"Immunovant, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1764013/0001764013-26-000064-index.html","primary_entity_key":"0001764013","primary_entity_name":"Immunovant, Inc."},"word_count":6,"has_tables":true,"body_markdown":"Item 1B.    Unresolved Staff Comments\n\nNone."}